Ignite Creation Date:
2024-05-05 @ 5:27 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00453687
Status:
COMPLETED
Last Update Posted:
2017-08-07
First Post:
2007-03-27
Brief Title:
A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK233705 In Healthy Volunteers
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A Single-centre Randomized Double-blind Placebo-controlled Dose-ascending Cross-over Study to Evaluate the Safety Tolerability Pharmacodynamics and Pharmacokinetics of Single Inhaled Doses of GSK233705 Formulated With the Excipient Magnesium Stearate in Healthy Volunteers
Status:
COMPLETED
Status Verified Date:
2017-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will investigate the safety and tolerability of inhaled doses of GSK233705 with a new formulation
Detailed Description:
A single-centre randomized double-blind placebo-controlled dose-ascending cross-over study to evaluate the safety tolerability pharmacodynamics and pharmacokinetics of single inhaled doses of GSK233705 50 100 and 200µg formulated with the excipient magnesium stearate in healthy volunteers
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None